Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

New Strong Buy Stocks for July 17th


Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

Pharming Group N.V. PHAR: This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing nearly 7% over the last 60 days.

Roku, Inc. ROKU: This operator of a TV streaming platform has seen the Zacks Consensus Estimate for its current year earnings increasing 5.3% over the last 60 days.

Roku, Inc. Price and Consensus

Roku, Inc. Price and Consensus

Roku, Inc. price-consensus-chart | Roku, Inc. Quote

ProKidney Corp. PROK: This clinical-stage biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 5.8% over the last 60 days.

MAG Silver Corp. MAG: This precious metal company has seen the Zacks Consensus Estimate for its current year earnings increasing 11.6% over the last 60 days.

Kimbell Royalty Partners, LP KRP: This oil and gas mineral and royalty company has seen the Zacks Consensus Estimate for its current year earnings increasing 83.3% over the last 60 days.

 

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Zacks' Research Chief Picks Stock Most Likely to "At Least Double"

Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.

See Our Top Stock to Double (Plus 4 Runners Up) >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
MAG Silver Corporation (MAG): Free Stock Analysis Report
 
Roku, Inc. (ROKU): Free Stock Analysis Report
 
Kimbell Royalty (KRP): Free Stock Analysis Report
 
Pharming Group N.V. Sponsored ADR (PHAR): Free Stock Analysis Report
 
ProKidney Corp. (PROK): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research


Source Zacks-com

At Zacks, we are dedicated to independent investment research, helping investors succeed through tools like our Zacks Rank stock-rating system, which has averaged +23.89% annual returns since 1988. Founded on the discovery that earnings estimate revisions drive stock prices, we offer purely mathematical, unbiased ratings, along with additional innovations like the Price Response Indicator, Earnings ESP, and specialized rankings for mutual funds and ETFs.
...
Legal notice

Comments